International Journal of Ophthalmology · Published 2026-07-16 · DOI 10.18240/ijo.2026.08.22
Qingdao Medical College, Qingdao University, Qingdao 266000, Shandong Province, China, Xiao-Han Jin, Mei-Qi Fan, Qingdao Medical College, Qingdao University, Qingdao 266000, Shandong Province, China, Yi-Zhuo Zhao, Binzhou Medical University, Yantai 264000, Shandong Province, China, Jun-Jie Ma, Yantai Yuhuangding Hospital, Qingdao University, Yantai 264000, Shandong Province, China, Yuan-Feng Zhang, Yantai Yuhuangding Hospital, Qingdao University, Yantai 264000, Shandong Province, China, Lu-Sheng Ma, Yantai Yuhuangding Hospital, Qingdao University, Yantai 264000, Shandong Province, China
Ocular graft-versus-host disease (oGVHD) is an immune disease that occurs in the eye after allogeneic hematopoietic stem cell transplantation and seriously affects the vision and quality of life of patients. Current treatment modalities are inadequate, and new treatment options and targets are required to improve the therapeutic efficacy of oGVHD. In recent years, a large number of studies have shown that exosomes, as important mediators of cell-to-cell communication, have important research value in the pathogenesis, diagnosis, and treatment of oGVHD. This article reviews the research progress on exosomes from different sources of oGVHD.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
China, Q., Jin, X., Fan, M., et al. (2026). Exosomes in ocular graft-versus-host disease: an overview. International Journal of Ophthalmology. https://doi.org/10.18240/ijo.2026.08.22